Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications
Molecular and ion sieving with angstrom-channels: general discussion.
Journal: Faraday discussions
Published: July 31, 2026
Cardiovascular Health Across the Life Course for Individuals With Breast Cancer: A Review.
Journal: JAMA cardiology
Published: July 29, 2026
Charging dynamics of angstrom-scale pores of MXene electrodes with ionic-liquid electrolytes.
Journal: Faraday discussions
Published: May 01, 2026
MRI-Based Deep Learning Guides Multi-Omics Discovery of NBPF4 as a Therapeutic Target for Breast Cancer Lymph Node Metastasis.
Journal: Research (Washington, D.C.)
Published: April 15, 2026
Association of LVOT Gradient and LA Strain with Cardiac Events in Pediatric HCM.
Journal: Pediatric cardiology
Published: March 10, 2026
Multimodality Approach to Coronary Ischemic Testing in Pediatric Patients: A Scientific Statement From the American Heart Association.
Journal: Journal of the American Heart Association
Published: February 26, 2026
Special collection on novel targeted therapies for advanced prostate cancer.
Journal: The Journal of pharmacology and experimental therapeutics
Published: December 18, 2025
Occult obstructive sleep apnea in survivors of Hodgkin lymphoma following radiation therapy: an atypical and under-recognized phenotype.
Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
Published: December 11, 2025
NUAK2 is a therapeutically tractable regulator of RNA splicing and tumor progression in neuroendocrine prostate cancer.
Journal: bioRxiv : the preprint server for biology
Published: November 26, 2025
Author Correction: An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.
Journal: Nature genetics
Published: October 22, 2025
Nonlocal dielectric response of aqueous electrolytes and decay behavior of ionic correlations.
Journal: Physical review. E
Published: June 12, 2025
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction.
Journal: Science (New York, N.Y.)
Published: June 12, 2025
Last Updated: 09/26/2026